Literature DB >> 25890628

Relation of perioperative elevation of troponin to long-term mortality after orthopedic surgery.

Brandon S Oberweis1, Nathaniel R Smilowitz2, Swetha Nukala3, Andrew Rosenberg4, Jinfeng Xu2, Steven Stuchin5, Richard Iorio5, Thomas Errico5, Martha J Radford2, Jeffrey S Berger6.   

Abstract

Myocardial necrosis in the perioperative period of noncardiac surgery is associated with short-term mortality, but long-term outcomes have not been characterized. We investigated the association between perioperative troponin elevation and long-term mortality in a retrospective study of consecutive subjects who underwent hip, knee, and spine surgery. Perioperative myocardial necrosis and International Classification of Disease, Ninth Revision-coded myocardial infarction (MI) were recorded. Long-term survival was assessed using the Social Security Death Index database. Logistic regression models were used to identify independent predictors of long-term mortality. A total of 3,050 subjects underwent surgery. Mean age was 60.8 years, and 59% were women. Postoperative troponin was measured in 1,055 subjects (34.6%). Myocardial necrosis occurred in 179 cases (5.9%), and MI was coded in 20 (0.7%). Over 9,015 patient-years of follow-up, 111 deaths (3.6%) occurred. Long-term mortality was 16.8% in subjects with myocardial necrosis and 5.8% with a troponin in the normal range. Perioperative troponin elevation (hazard ratio 2.33, 95% confidence interval 1.33 to 4.10) and coded postoperative MI (adjusted hazard ratio 3.51, 95% confidence interval 1.44 to 8.53) were significantly associated with long-term mortality after multivariable adjustment. After excluding patients with coronary artery disease and renal dysfunction, myocardial necrosis remained associated with long-term mortality. In conclusion, postoperative myocardial necrosis is common after orthopedic surgery. Myocardial necrosis is independently associated with long-term mortality at 3 years and may be used to identify patients at higher risk for events who may benefit from aggressive management of cardiovascular risk factors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25890628      PMCID: PMC5568001          DOI: 10.1016/j.amjcard.2015.03.003

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  Does cardiology intervention improve mortality for post-operative troponin elevations after emergency orthopaedic-geriatric surgery? A randomised controlled study.

Authors:  Carol P Chong; William J van Gaal; Julie E Ryan; Konstantinos Profitis; Judy Savige; Wen Kwang Lim
Journal:  Injury       Date:  2012-04-26       Impact factor: 2.586

2.  Quality of postoperative care after major orthopedic surgery is correlated with both long-term cardiovascular outcome and troponin Ic elevation.

Authors:  Sylvain Ausset; Yves Auroy; Catherine Verret; Dan Benhamou; Philippe Vest; Audrey Cirodde; Bernard Lenoir
Journal:  Anesthesiology       Date:  2010-09       Impact factor: 7.892

3.  Cardiac troponin I release after hip surgery correlates with poor long-term cardiac outcome.

Authors:  S Ausset; Y Auroy; E Lambert; P Vest; C Plotton; S Rigal; B Lenoir; D Benhamou
Journal:  Eur J Anaesthesiol       Date:  2007-08-01       Impact factor: 4.330

4.  Incidence of post-operative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients.

Authors:  Carol P Chong; Que T Lam; Julie E Ryan; Rabindra N Sinnappu; Wen Kwang Lim
Journal:  Age Ageing       Date:  2008-11-13       Impact factor: 10.668

5.  Troponin I as a diagnostic marker of a perioperative myocardial infarction in the orthopedic population.

Authors:  K Jules-Elysee; M K Urban; B Urquhart; S Milman
Journal:  J Clin Anesth       Date:  2001-12       Impact factor: 9.452

6.  Prevalence, health care expenditures, and orthopedic surgery workforce for musculoskeletal conditions.

Authors:  Robert H Haralson; Joseph D Zuckerman
Journal:  JAMA       Date:  2009-10-14       Impact factor: 56.272

7.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard R Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Jeroen J Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasche; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; Jose-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Joao Morais; Carlos Aguiar; Wael Almahmeed; David O Arnar; Fabio Barili; Kenneth D Bloch; Ann F Bolger; Hans Erik Botker; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; James de Lemos; Franz R Eberli; Edgardo Escobar; Mark Hlatky; Stefan James; Karl B Kern; David J Moliterno; Christian Mueller; Aleksandar N Neskovic; Burkert Mathias Pieske; Steven P Schulman; Robert F Storey; Kathryn A Taubert; Pascal Vranckx; Daniel R Wagner
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

8.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery.

Authors:  P J Devereaux; Matthew T V Chan; Pablo Alonso-Coello; Michael Walsh; Otavio Berwanger; Juan Carlos Villar; C Y Wang; R Ignacio Garutti; Michael J Jacka; Alben Sigamani; Sadeesh Srinathan; Bruce M Biccard; Clara K Chow; Valsa Abraham; Maria Tiboni; Shirley Pettit; Wojciech Szczeklik; Giovanna Lurati Buse; Fernando Botto; Gordon Guyatt; Diane Heels-Ansdell; Daniel I Sessler; Kristian Thorlund; Amit X Garg; Marko Mrkobrada; Sabu Thomas; Reitze N Rodseth; Rupert M Pearse; Lehana Thabane; Matthew J McQueen; Tomas VanHelder; Mohit Bhandari; Jackie Bosch; Andrea Kurz; Carisi Polanczyk; German Malaga; Peter Nagele; Yannick Le Manach; Martin Leuwer; Salim Yusuf
Journal:  JAMA       Date:  2012-06-06       Impact factor: 56.272

9.  Thrombotic and bleeding complications after orthopedic surgery.

Authors:  Brandon S Oberweis; Swetha Nukala; Andrew Rosenberg; Yu Guo; Steven Stuchin; Martha J Radford; Jeffrey S Berger
Journal:  Am Heart J       Date:  2013-01-08       Impact factor: 4.749

10.  The one year incidence of postoperative myocardial infarction in an orthopedic population.

Authors:  M K Urban; K Jules-Elysee; C Loughlin; W Kelsey; E Flynn
Journal:  HSS J       Date:  2007-12-11
View more
  17 in total

1.  Perioperative antiplatelet therapy and cardiovascular outcomes in patients undergoing joint and spine surgery.

Authors:  Nathaniel R Smilowitz; Brandon S Oberweis; Swetha Nukala; Andrew Rosenberg; Steven Stuchin; Richard Iorio; Thomas Errico; Martha J Radford; Jeffrey S Berger
Journal:  J Clin Anesth       Date:  2016-08-19       Impact factor: 9.452

2.  Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research.

Authors:  Ann Marie Navar; Eric D Peterson; Dylan L Steen; Daniel M Wojdyla; Robert J Sanchez; Irfan Khan; Xue Song; Matthew E Gold; Michael J Pencina
Journal:  JAMA Cardiol       Date:  2019-04-01       Impact factor: 14.676

3.  Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery.

Authors:  Nathaniel R Smilowitz; Joshua A Beckman; Scott E Sherman; Jeffrey S Berger
Journal:  Circulation       Date:  2018-03-10       Impact factor: 29.690

Review 4.  [Perioperative myocardial ischemia : Current aspects and concepts].

Authors:  B Bein; R Schiewe; J Renner
Journal:  Anaesthesist       Date:  2019-08       Impact factor: 1.041

5.  Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery.

Authors:  Nathaniel R Smilowitz; Navdeep Gupta; Harish Ramakrishna; Yu Guo; Jeffrey S Berger; Sripal Bangalore
Journal:  JAMA Cardiol       Date:  2017-02-01       Impact factor: 14.676

Review 6.  The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Authors:  Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

Review 7.  Perioperative Management to Reduce Cardiovascular Events.

Authors:  Nathaniel R Smilowitz; Jeffrey S Berger
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

8.  Medical therapy for atherosclerotic cardiovascular disease in patients with myocardial injury after non-cardiac surgery.

Authors:  Jin F Chen; Nathaniel R Smilowitz; Jung T Kim; Germaine Cuff; Alina Boltunova; Jason Toffey; Jeffrey S Berger; Andrew Rosenberg; Samir Kendale
Journal:  Int J Cardiol       Date:  2018-12-12       Impact factor: 4.164

9.  Characteristics and long-term mortality of patients with ST-elevation or non-ST-elevation myocardial infarction after orthopaedic surgery.

Authors:  Wenlan Hu; Kaiping Zhao; Youzhou Chen; Jihong Wang; Mei Zheng; Ying Zhao; Qiong Zhao; Xingshan Zhao
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

10.  Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients.

Authors:  Anne R Bass; Jackie D Szymonifka; Matthew T Rondina; Margaret Bogardus; Mitchell G Scott; Scott C Woller; Scott M Stevens; Charles Eby; Kerri Merritt; Alejandro Gonzalez Della Valle; Gerard Moskowitz; Eva Flores; Brian F Gage
Journal:  HSS J       Date:  2017-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.